| Mobile Web

Samsung Electronics becomes top shareholder in U.S. Element Biosciences to bolster precision medicine technology

Samsung Electronics said on Tuesday it made a strategic investment in U.S. gene analysis equipment company Element Biosciences and became its top shareholder. Samsung invested an additional $175 million by participating in Element’s Series E round, after taking part in its Series D investment in July 2024. Samsung said the investment would help it secure key technologies in the fast-growing global precision medicine market and strengthen future growth engines.